Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Business Information

Tell us about your organization

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

About Ingenious Med

Headquarters:

Atlanta Georgia, United States

Sector Funding:

Go to Website

Preferences

   Bookmark

Ingenious Med's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

Revenue cycle services
Free additional provider licenses and multiple pandemic-management enhancements

As patient volumes and care delivery needs grow, hospitals and providers must scale appropriately. Maintaining workflow efficiency and revenue integrity will require a wider range of care team members to access our platform. That’s why we are now allowing our customers to add provider licenses free of charge through September 30, 2020. At that time, they can keep those licenses under their current contract terms or remove the additional licenses at no charge.

Ingenious Med has also fast-tracked multiple pandemic-management enhancements to help our customers address the COVID-19 crisis more effectively:

  • New CMS COVID-19 coding. We added the recently released U07.1 COVID-19 code to our platform on March 26, 2020.
  • Telemedicine billing. More providers are taking advantage of relaxed telemedicine regulations to quickly limit viral exposure and extend coverage to understaffed facilities. We deployed the 95 telemedicine modifier so customers can track and bill virtual encounters accurately.
  • COVID-19 and telemedicine superbills. Our updated superbills make it easy for providers to find and designate the appropriate codes.
  • Optional patient flags. If administrators enable them, providers can add COVID-19 positive or suspected flags to identify patients quickly and easily.
  • Teams for cohorting. We have several options for limiting exposure to healthcare workers through identifying distinct COVID-19 teams and assigning patients to them.
  • Reporting and dashboards. Our automated daily reports with dashboards provide COVID-19 patient list status and trends to monitor their progress and the required treatment resources.

Finally, we implemented accelerated new-user training and additional resources so more providers can use all our tools and reporting more quickly and effectively.


Best in KLAS Awards


Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Software Overall Score Data collected between Feb 2020 - Feb 2021

78.6

 Product
Segment
 

Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

# of Unique Organization Evaluations:

0 - 5
L 6 - 14

Segment Position

Segment positions refer to the order in which this product is scored among competitors’ products within its market segment.

In order to be scored in a segment, the product must have sufficient data levels and be equivalent in scope to other products within that segment.

Click the segment positions listed below to learn more.